A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 American Society of Clinical ...

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

The results are still preliminary, but Pfizer said that if it hits primary endpoints later this year could form ... its full dose once a week thereafter. J&J also reported new data at ASCO from ...

For example, evidence demonstrates completing of a full course of ASN is directly associated with ... global partnerships among pharmaceutical procurers. Such partnerships can form the groundwork for ...

Over 230 patients enrolled in potential registration-enabling trial in 1L HLA-A2-negative MUM, and median PFS readout targeted by year-end 202595 patients enrolled in neoadjuvant UM trial and ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

“Eating lots of plant nutrients like flavonoids from food forms, rather than consuming it in pill, powder, or juice form ... full and what our taste buds are desiring, then the amount of sweets will ...

RRB Full Form: The full form of RRB is Railway Recruitment Board. Established in 1998, the RRB operates under the Ministry of Railways and is responsible for recruiting individuals for various ...

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) and director of the ...

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...